Cannabis Report
Home > Boards > US Listed > Biotechs >

Nabriva Therapeutics AG (NBRV)

NBRV RSS Feed 		Add NBRV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/4/2018 3:46:00 PM - Followers: 13 - Board type: Free - Posts Today: 0

Nabriva Therapeutics AG Leberstrasse 20 Vienna, 1110 Austria Phone: 43 1 740 93 0 Fax: 43 1 740 93 1900 Website: http://www.nabriva.com Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It is also developing BC-7013, a topical pleuromutilin product candidate, which has completed a Phase 1 clinical trial. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics AG in 2007. Nabriva Therapeutics AG was incorporated in 2005 and is headquartered in Vienna, Austria.
Cannabis Report
NBRV
Current Price
Volume:
Bid Ask Day's Range
NBRV Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NBRV News: Statement of Changes in Beneficial Ownership (4) 06/26/2018 09:12:13 AM
NBRV News: Statement of Changes in Beneficial Ownership (4) 06/25/2018 09:49:04 AM
NBRV News: Statement of Changes in Beneficial Ownership (4) 06/25/2018 09:48:28 AM
NBRV News: Proxy Statement (definitive) (def 14a) 06/19/2018 04:19:44 PM
NBRV News: Current Report Filing (8-k) 06/19/2018 04:07:34 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#73   Great Top line late stage Lefamulin drug cash_cow1 06/04/18 03:46:00 PM
#72   Continuing large insiders buying being filed with the cash_cow1 06/04/18 02:30:20 PM
#71   Nabriva Therapeutics employees is now buying large shares cash_cow1 05/24/18 10:10:52 AM
#70   Nabriva "the company" believe strongly in its products. cash_cow1 05/24/18 09:58:45 AM
#69   Large insiders buying yesterday filed with the SEC. cash_cow1 05/24/18 09:52:10 AM
#68   gen sec insider buy realfast95 05/23/18 12:45:20 PM
#67   DJ Nabriva Therapeutics Price Target Raised to $11.00/Share realfast95 05/22/18 11:23:09 AM
#66   Brett Jensen tweet realfast95 05/22/18 08:41:03 AM
#65   Nabriva Falls On Lefamulin Safety Concerns, But Issues realfast95 05/22/18 06:45:16 AM
#64   Cantor Fitzgerald did the last stock offering, of Acen176 05/21/18 08:53:13 PM
#63   H.C. Wainwright Thinks Nabriva’s Stock is Going to Recover realfast95 05/21/18 07:49:06 PM
#62   https://www.markets.co/h-c-wainwright-thinks-nabrivas-stock-is-going-to-recover/ realfast95 05/21/18 07:06:49 PM
#61   I read more positive than negative [SMART MONEY] 05/21/18 06:36:42 PM
#60   Thanks...already sold half on a bounce to 4.95. girlfriend 05/21/18 12:14:40 PM
#59   you might get a bounce, but the big realfast95 05/21/18 12:13:14 PM
#58   https://www.cnbc.com/2018/05/21/reuters-america-update-3-nabriva-shares-tumble-a girlfriend 05/21/18 12:08:48 PM
#57   Overreaction? Are you buying? girlfriend 05/21/18 12:01:04 PM
#56   tweet BioWorld ? @BioWorld realfast95 05/21/18 11:57:48 AM
#55   Nbrv. Stools. 70% mild. 30% moderate. No drop randychub 05/21/18 11:49:43 AM
#54   tweet Bryan Green realfast95 05/21/18 11:48:25 AM
#53   Grabbed some 4.77's hope I want them. girlfriend 05/21/18 10:21:48 AM
#52   NBRV ma(50) 5.04 [SMART MONEY] 05/21/18 10:06:24 AM
#51   red 5.25 unreal [SMART MONEY] 05/21/18 09:57:29 AM
#50   Nice! > PT of $18 & $16. > crudeoil24 05/21/18 09:07:18 AM
#49   added 6.18's to my 6.29's [SMART MONEY] 05/21/18 09:04:18 AM
#48   those May option holders are probably not happy realfast95 05/21/18 08:56:22 AM
#47   FDA III > https://ih.advfn.com/p.php?pid=nmona&article=77476430 crudeoil24 05/21/18 08:16:41 AM
#46   positive top line results are announced realfast95 05/21/18 08:08:21 AM
#45   no results tonight. The last due day is 6/20/18 realfast95 05/16/18 08:21:52 PM
#44   wrong time zone. 5:15 Las Vegas time realfast95 05/16/18 05:55:50 PM
#43   Nabriva Therapeutics at the Bank of America Merrill realfast95 05/15/18 03:53:51 PM
#42   5/8/2018 Needham & Company LLC Reiterated Rating Buy $18.00 realfast95 05/10/18 05:50:35 AM
#41   First Quarter 2018 Financial results realfast95 05/08/18 09:14:41 AM
#40   Those are exchange traded options. We were nsomniyak 05/06/18 11:50:10 AM
#39   Mr. covered call with all of his objectivity lmao. faxedreceipts 05/05/18 10:49:15 PM
#38   no, that is not true. Typically options nsomniyak 05/05/18 05:33:54 PM
#37   options granted, filings. Good to see this line realfast95 05/04/18 04:15:59 PM
#36   Now I'm nervous realfast95 04/27/18 03:50:52 PM
#35   $7.5 May 18th options getting some interest realfast95 04/26/18 04:18:05 PM
#34   That is what I had been waiting for, realfast95 04/23/18 09:44:29 AM
#33   Friday 4/20 after the close 8K realfast95 04/23/18 09:43:46 AM
#32   Nabriva Therapeutics to Present Data at ECCMID Demonstrating realfast95 04/13/18 09:10:05 AM
#31   WOW! Nice 13.7% stake in NBRV by Wellington! bUrRpPPP! 04/11/18 05:47:54 AM
#30   well this amateur likes all the different tables realfast95 04/10/18 04:09:19 PM
#29   Use SEC.GOV...Nasdaq.com is for amateurs. faxedreceipts 04/10/18 03:58:18 PM
#28   very odd, the NBRV SEC filings stop in realfast95 04/10/18 03:49:08 PM
#27   Wellington Management Group owns 14 percent as of faxedreceipts 04/10/18 02:54:28 PM
#26   http://www.wbtv.com/story/37883802/antibiotic-resistant-nightmare-bacteria-a-gro faxedreceipts 04/05/18 09:39:49 AM
#25   True especially if the sellers are ambushed by faxedreceipts 04/03/18 10:56:16 AM
#24   If phase 3 results are good? sales randychub 04/03/18 10:34:22 AM
PostSubject
© 2018 InvestorsHub.com, Inc.